Clinical Trial Update: Characteristics and Mechanism of Denosumab-treated Giant Cell Tumor of Bone [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update detailing the characteristics and mechanism of denosumab in giant cell tumor of bone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Tumor of Bone

Drugs mentioned

• Xgeva (denosumab)

Snippet

Sponsor: Hebei Medical University Third Hospital | Conditions: Giant Cell Tumor of Bone | Phase 3 | Status: UNKNOWN